Deepureskin

Deepureskin
Gerbang Anda untuk mendunia telah terbuka. Segera buat website dan email deepureskin.xyz dan mulai perjalanan bisnis Anda.
About
What does Deepureskin do?
Deepureskin.xyz offers website hosting and domain services, enabling users to create professional email addresses and build their own websites. The platform provides tutorials and support for tasks such as setting up email accounts, designing websites using tools like SitePro and WordPress, and registering domains.
When was Deepureskin founded?
Deepureskin was founded in 2026.
What industry does Deepureskin operate in?
Deepureskin operates in Web Presence, Website Builder, Email Services, Business Services, Digital Transformation, Website Hosting.
What is Deepureskin's current status?
Deepureskin's current operating status is: Inactive.
Elucor is a SaaS platform that enables users to create a live website from an idea in minutes, offering free credits and sign-up options.
An upcoming website building platform providing a contact form for updates and promotions.
An AI coding platform that empowers users to build and scale high-performing websites and applications by chatting with AI.
Build, manage & grow your business online with CruxFlo — an AI-powered platform with websites, CRM, automations, bookings, email & WhatsApp.
Website, AI chat, and a task workspace for 1-3 person trade businesses to never miss a lead.
Create engaging landing pages that effectively capture leads and promote products, tailored for businesses looking to enhance their online presence.
AI agents deeply integrated with WordPress for product selection, website building, SEO, content, and affiliate monetization.
AI-powered website creation for small businesses with a personal touch.
An entrant is a company tagged Website Builder whose domain was first registered in the window, counted from registry records in the StartupHub directory. 5 of them registered in the last 30 days. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.

